UPDATE: Piper Sandler Starts Lexicon Pharmaceuticals (LXRX) at Overweight

August 12, 2022 3:31 AM EDT Send to a Friend
(Updated - August 12, 2022 5:21 AM EDT)

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Lexicon Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login